Welcome guest, Sign in

Home

X
加载中

The purpose of stability testing is to determine how the properties of a particular therapeutic vary with time under the influence of specific environmental factors. Information regarding the long-term stability of therapeutics can be extrapolated by performing an accelerated storage stability study. Here, we describe an accelerated storage stability study for the potential anti-anthrax therapeutic, EnvD, a poly-γ-D-glutamic acid (PDGA) depolymerase. Storage conditions were based on those recommended by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Owing to the high-molecular-weight and associated viscosity of PDGA in solution, loss of enzyme activity on storage can be determined as a reduction in the capacity of the depolymerase to reduce the viscosity of the polymer. This work supported by a Medical Research Council Capacity Building Studentship award.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Accelerated Storage Stability Testing of a Potential Anti-Anthrax Therapeutic, EnvD

Microbiology > Microbial biochemistry > Protein > Activity
Authors: David Negus
David NegusAffiliation: University College London School of Pharmacy, London, UK
For correspondence: d.negus@ucl.ac.uk
Bio-protocol author page: a1761
 and Peter W. Taylor
Peter W. TaylorAffiliation: University College London School of Pharmacy, London, UK
Bio-protocol author page: a1762
Vol 4, Iss 21, 11/5/2014, 1518 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1281

[Abstract] The purpose of stability testing is to determine how the properties of a particular therapeutic vary with time under the influence of specific environmental factors. Information regarding the long-term stability of therapeutics can be extrapolated by performing an accelerated storage stability study. Here, we describe an accelerated storage stability study for the potential anti-anthrax therapeutic, EnvD, a poly-γ-D-glutamic acid (PDGA) depolymerase. Storage conditions were based on those recommended by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Owing to the high-molecular-weight and associated viscosity of PDGA in solution, loss of enzyme activity on storage can be determined as a reduction in the capacity of the depolymerase to reduce the viscosity of the polymer. This work supported by a Medical Research Council Capacity Building Studentship award.

Materials and Reagents

  1. Poly-γ-D-glutamic acid [prepared in-house; protocol for production can be found in Negus and Taylor (2014)]
  2. Recombinant EnvD enzyme (prepared in-house)
  3. PBS (Thermo Fisher Scientific, catalog number: 12821680)
  4. Distilled water (prepared in-house)
  5. Compressed air (prepared in-house)
  6. 70% ethanol (see Recipes)

Equipment

  1. 1.5 ml microcentrifuge tubes (Eppendorf, catalog number: 0030120086)
  2. Parafilm (Pechiney Plastic Packaging, catalog number: PM996)
  3. 5 ml sterile plastic syringes (Terumo Medical Corporation, catalog number: SS-05S)
  4. Static incubator (Unitemps, discontinued) (B&T)
  5. Micro-viscometer (Anton Paar GmbH, model: AMVn, catalog number: 1569)
  6. Glass capillary for micro-viscometer (1.6 mm internal diameter) (Anton Paar GmbH, catalog number: 67605)
  7. Steel balls (1.5 mm diameter) (Anton Paar GmbH, catalog number: 73109)
  8. Capillary filling adapater (Anton Paar GmbH, catalog number: 63390)

Procedure

  1. Aliquots of freshly isolated EnvD (35 µg total protein) were adjusted to a final volume of 50 µl with sterile PBS in 1.5 ml microcentrifuge tubes and sealed with Parafilm.
  2. Microcentrifuge tubes were maintained at 37 °C over a period of 30 days to simulate long-term storage. The temperature of the incubator was periodically checked to ensure it did not fluctuate by more than ± 2 °C.
  3. Samples of EnvD were periodically (0 days, 1 day, 3 days, 7 days, 15 days, 30 days) removed from the incubator and rapidly combined with 400 µg of lyophilised PDGA substrate suspended in 1 ml of PBS.
  4. Reactions were allowed to proceed for 1 h at 37 °C in a static incubator and were terminated by heating at 95 °C for 10 min. Samples were stored at -20 °C before viscometeric analysis.
  5. Viscosity of PDGA following incubation with stored enzyme preparations was determined using an Anton Paar falling ball microviscometer. Frozen samples were thawed at room temperature and transferred to a glass viscometry capillary containing a solid steel ball using a 5 ml syringe and filling adapter.
  6. Viscosity was determined as the time taken for the ball to fall 25 cm through the sample at an angle of 15° to the horizontal; each automated, timed determination was performed four times.
  7. After each reading the capillary was cleaned with distilled water followed by 70% ethanol. The capillary was then dried with compressed air.

Representative data


Figure 1. Stability of rEnvD during accelerated storage at elevated temperature. Samples of rEnvD were maintained at 37 °C for 30 d. At the time points indicated, aliquots were combined with PDGA (400 μg/ml), incubated for 1 h at 37 °C and the rune time determined. Ball run time (s) was measured in an Anton-Paar AMVn viscometer; the time taken for the ball to fall 25 cm at an angle of 15° to the horizontal was determined. Error bars represent ± 1 SD (n=8).

Recipes

  1. 70% ethanol
    700 ml ethanol
    300 ml distilled water

Acknowledgments

This work supported by a Medical Research Council Capacity Building Studentship award.

References

  1. Kimura, K. and Itoh, Y. (2003). Characterization of poly-gamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-gamma-glutamate. Appl Environ Microbiol 69(5): 2491-2497.
  2. Negus, D. and Taylor, P. W. (2014). A poly-gamma-(D)-glutamic acid depolymerase that degrades the protective capsule of Bacillus anthracis. Mol Microbiol 91(6): 1136-1147.


How to cite this protocol: Negus, D. and Taylor, P. W. (2014). Accelerated Storage Stability Testing of a Potential Anti-Anthrax Therapeutic, EnvD. Bio-protocol 4(21): e1281. DOI: 10.21769/BioProtoc.1281; Full Text



Share Your Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook